Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Authors

Wan Li
Jie Yi
Xiangjin Zheng
Shiwei Liu
Weiqi Fu
Liwen Ren
Li Li
Dave Hoon, Department of Translational Molecular Medicine, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.Follow
Jinhua Wang
Guanhua Du

Document Type

Article

Publication Date

7-29-2022

Publication Title

Clin Epigenetics

Keywords

california; sjci; santa monica

Clinical Institute

Women & Children

Clinical Institute

Cancer

Department

Oncology

Recommended Citation

Li, Wan; Yi, Jie; Zheng, Xiangjin; Liu, Shiwei; Fu, Weiqi; Ren, Liwen; Li, Li; Hoon, Dave; Wang, Jinhua; and Du, Guanhua, "Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway." (2022). Articles, Abstracts, and Reports. 6421.
https://digitalcommons.providence.org/publications/6421